Search - tctmd.com

Displaying 81 - 100 of 571

Sort: Relevancy | Date

Presentation TCT 2022

TCT 232: Head-to-head comparison of two different angiography-derived FFR techniques in NSTEMI patients

Presenter: Ioannis Skalidis

September 17, 2022

Presentation TCT 2022

TCT 258: Instantaneous wave free ratio for the assessment of intermediate left main coronary artery stenosis. Correlations with FFR/IVUS and prognostic implications. The iLITRO - EPIC07 study

Presenter: Oriol Rodriguez Leor

September 17, 2022

Presentation TCT 2022

TCT 257: FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: 2-year Results from the FFR REACT Trial

Presenter: Joost Daemen

September 17, 2022

Presentation TCT 2022

Practical Integration of FFRangio in Today’s Cath Lab

Presenter: Amir Kaki

September 17, 2022

Presentation TCT 2022

How FFRangio is Changing the Game

Presenter: Rahul Sharma

September 17, 2022

Presentation TCT 2022

FFRangio from Concept to Reality

Presenter: Ran Kornowski

September 17, 2022

Presentation TCT 2022

The Need for Physiology in a Long Tradition of Disruptive Technologies

Presenter: Martin Leon

September 17, 2022

Presentation TCT 2022

INOCA: Noninvasive vs Invasive Diagnostic Approach – FFR, CFR, IMR

Presenter: Jennifer Tremmel

September 17, 2022

Presentation TCT 2021

Case Presentation 1 Case: Vulnerable Stenosis by CTA, but FFR Negative or Borderline (From Dr. Koo); Vulnerable Stenosis by OCT/IVUS/NIRS/s Ischemia (From Dr. Erlinge)

Presenter: Jeehoon Kang

November 06, 2021

Presentation TCT 2021

FFR REACT: A Randomized Trial of FFR-Guided PCI Optimization by IVUS Versus No Optimization

Presenter: Joost Daemen

November 05, 2021

Presentation TCT 2021

Case 1: Provisional With One Stent – Does FFR Help Us?

Presenter: Bon-Kwon Koo

November 04, 2021

News Conference News TCT 2021

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Caitlin E. Cox

November 04, 2021

Presentation TCT 2021

iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

Presenter: Matthias Götberg

November 04, 2021

News Conference News TCT 2021

FAVOR III China Adds Strength to Value of QFR-Guided PCI

L.A. McKeown

November 04, 2021

Presentation TCT 2021

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

Presenter: William Fearon

November 04, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

Presentation TCT 2021

TCT 82: Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events: Insights From the COMBINE FFR-OCT Trial

Presenter: Wojciech Wojakowski

November 04, 2021

News Conference News TCT 2020

No Cost Savings With Routine FFRCT for New-Onset Chest Pain: FORECAST

Michael O'Riordan

October 21, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News TCT 2020

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

Michael O'Riordan

October 17, 2020

Advertisement

TCT 232: Head-to-head comparison of two different angiography-derived FFR techniques in NSTEMI patients

TCT 258: Instantaneous wave free ratio for the assessment of intermediate left main coronary artery stenosis. Correlations with FFR/IVUS and prognostic implications. The iLITRO - EPIC07 study

TCT 257: FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: 2-year Results from the FFR REACT Trial

Practical Integration of FFRangio in Today’s Cath Lab

How FFRangio is Changing the Game

FFRangio from Concept to Reality

The Need for Physiology in a Long Tradition of Disruptive Technologies

INOCA: Noninvasive vs Invasive Diagnostic Approach – FFR, CFR, IMR

Case Presentation 1 Case: Vulnerable Stenosis by CTA, but FFR Negative or Borderline (From Dr. Koo); Vulnerable Stenosis by OCT/IVUS/NIRS/s Ischemia (From Dr. Erlinge)

FFR REACT: A Randomized Trial of FFR-Guided PCI Optimization by IVUS Versus No Optimization

Case 1: Provisional With One Stent – Does FFR Help Us?

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

FAVOR III China Adds Strength to Value of QFR-Guided PCI

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

TCT 82: Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events: Insights From the COMBINE FFR-OCT Trial

No Cost Savings With Routine FFRCT for New-Onset Chest Pain: FORECAST

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content